Literature DB >> 18666155

Comparison of T(1) and T(2) metabolite relaxation times in glioma and normal brain at 3T.

Yan Li1, Radhika Srinivasan, Helene Ratiney, Ying Lu, Susan M Chang, Sarah J Nelson.   

Abstract

PURPOSE: To measure T(1) and T(2) relaxation times of metabolites in glioma patients at 3T and to investigate how these values influence the observed metabolite levels.
MATERIALS AND METHODS: A total of 23 patients with gliomas and 10 volunteers were studied with single-voxel two-dimensional (2D) J-resolved point-resolved spectral selection (PRESS) using a 3T MR scanner. Voxels were chosen in normal appearing white matter (WM) and in regions of tumor. The T(1) and T(2) of choline containing compounds (Cho), creatine (Cr), and N-acetyl aspartate (NAA) were estimated.
RESULTS: Metabolite T(1) relaxation values in gliomas were not significantly different from values in normal WM. The T(2) of Cho and Cr were statistically significantly longer for grade 4 gliomas than for normal WM but the T(2) of NAA was similar. These differences were large enough to impact the corrections of metabolite levels for relaxation times with tumor grade in terms of metabolite ratios (P < 0.001).
CONCLUSION: The differential increase in T(2) for Cho and Cr relative to NAA means that the ratios of Cho/NAA and Cr/NAA are higher in tumor at longer echo times (TEs) relative to values in normal appearing brain. Having this information may be useful in defining the acquisition parameters for optimizing contrast between tumor and normal tissue in MR spectroscopic imaging (MRSI) data, in which limited time is available and only one TE can be used. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18666155      PMCID: PMC3033227          DOI: 10.1002/jmri.21453

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  35 in total

1.  Proton NMR chemical shifts and coupling constants for brain metabolites.

Authors:  V Govindaraju; K Young; A A Maudsley
Journal:  NMR Biomed       Date:  2000-05       Impact factor: 4.044

2.  Proton T (1) and T (2) relaxation times of human brain metabolites at 3 Tesla.

Authors:  V Mlynárik; S Gruber; E Moser
Journal:  NMR Biomed       Date:  2001-08       Impact factor: 4.044

Review 3.  Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death.

Authors:  José M Matés; Cristina Pérez-Gómez; Ignacio Núñez de Castro; Maite Asenjo; Javier Márquez
Journal:  Int J Biochem Cell Biol       Date:  2002-05       Impact factor: 5.085

4.  (1R,3S)-1-Aminocyclopentane-1,3-dicarboxylic acid (RS-ACPD) reduces intracellular glutamate levels in astrocytes.

Authors:  Z C Ye; B R Ransom; H Sontheimer
Journal:  J Neurochem       Date:  2001-11       Impact factor: 5.372

5.  Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localised proton spectroscopy of brain.

Authors:  M Kaminogo; H Ishimaru; M Morikawa; M Ochi; R Ushijima; M Tani; Y Matsuo; J Kawakubo; S Shibata
Journal:  Neuroradiology       Date:  2001-05       Impact factor: 2.804

6.  Glutamate release promotes growth of malignant gliomas.

Authors:  T Takano; J H Lin; G Arcuino; Q Gao; J Yang; M Nedergaard
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

7.  Correlation of myo-inositol levels and grading of cerebral astrocytomas.

Authors:  M Castillo; J K Smith; L Kwock
Journal:  AJNR Am J Neuroradiol       Date:  2000-10       Impact factor: 3.825

8.  Quantification of cerebral metabolites in glioma patients with proton MR spectroscopy using T2 relaxation time correction.

Authors:  Tomonori Isobe; Akira Matsumura; Izumi Anno; Takashi Yoshizawa; Yasushi Nagatomo; Yuji Itai; Tadao Nose
Journal:  Magn Reson Imaging       Date:  2002-05       Impact factor: 2.546

9.  1H chemical shift imaging characterization of human brain tumor and edema.

Authors:  Paul E Sijens; Matthijs Oudkerk
Journal:  Eur Radiol       Date:  2002-02-09       Impact factor: 5.315

10.  Eliminating spurious lipid sidebands in 1H MRS of breast lesions.

Authors:  Patrick J Bolan; Lance DelaBarre; Eva H Baker; Hellmut Merkle; Lenore I Everson; Douglas Yee; Michael Garwood
Journal:  Magn Reson Med       Date:  2002-08       Impact factor: 4.668

View more
  31 in total

Review 1.  Imaging tumor metabolism using in vivo magnetic resonance spectroscopy.

Authors:  Yan Li; Ilwoo Park; Sarah J Nelson
Journal:  Cancer J       Date:  2015 Mar-Apr       Impact factor: 3.360

Review 2.  Quantitative relaxometry of the brain.

Authors:  Sean C L Deoni
Journal:  Top Magn Reson Imaging       Date:  2010-04

3.  Improved spatial coverage for brain 3D PRESS MRSI by automatic placement of outer-volume suppression saturation bands.

Authors:  Eugene Ozhinsky; Daniel B Vigneron; Sarah J Nelson
Journal:  J Magn Reson Imaging       Date:  2011-04       Impact factor: 4.813

4.  MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial.

Authors:  Patrick J Bolan; Eunhee Kim; Benjamin A Herman; Gillian M Newstead; Mark A Rosen; Mitchell D Schnall; Etta D Pisano; Paul T Weatherall; Elizabeth A Morris; Constance D Lehman; Michael Garwood; Michael T Nelson; Douglas Yee; Sandra M Polin; Laura J Esserman; Constantine A Gatsonis; Gregory J Metzger; David C Newitt; Savannah C Partridge; Nola M Hylton
Journal:  J Magn Reson Imaging       Date:  2016-12-16       Impact factor: 4.813

5.  Comparison between Short and Long Echo Time Magnetic Resonance Spectroscopic Imaging at 3T and 7T for Evaluating Brain Metabolites in Patients with Glioma.

Authors:  Yan Li; Marisa Lafontaine; Susan Chang; Sarah J Nelson
Journal:  ACS Chem Neurosci       Date:  2017-10-16       Impact factor: 4.418

6.  Proton T2 measurement and quantification of lactate in brain tumors by MRS at 3 Tesla in vivo.

Authors:  Akshay Madan; Sandeep K Ganji; Zhongxu An; Kevin S Choe; Marco C Pinho; Robert M Bachoo; Elizabeth M Maher; Changho Choi
Journal:  Magn Reson Med       Date:  2014-07-07       Impact factor: 4.668

7.  Quantification of muscle choline concentrations by proton MR spectroscopy at 3 T: technical feasibility.

Authors:  Laura M Fayad; Nouha Salibi; Xin Wang; Antonio J Machado; Michael A Jacobs; David A Bluemke; Peter B Barker
Journal:  AJR Am J Roentgenol       Date:  2010-01       Impact factor: 3.959

8.  Assessment of subchondral bone marrow lipids in healthy controls and mild osteoarthritis patients at 3T.

Authors:  Ligong Wang; Nouha Salibi; Gregory Chang; Renata L R Vieira; James S Babb; Svetlana Krasnokutsky; Steven Abramson; Ravinder R Regatte
Journal:  NMR Biomed       Date:  2011-08-18       Impact factor: 4.044

9.  Potential clinical impact of multiparametric quantitative MR spectroscopy in neurological disorders: A review and analysis.

Authors:  Ivan I Kirov; Assaf Tal
Journal:  Magn Reson Med       Date:  2019-08-08       Impact factor: 4.668

10.  Relaxation times of skeletal muscle metabolites at 7T.

Authors:  Ligong Wang; Nouha Salibi; Yan Wu; Mark E Schweitzer; Ravinder R Regatte
Journal:  J Magn Reson Imaging       Date:  2009-06       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.